GENE ONLINE|News &
Opinion
Blog

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless

WRITTEN BY Joy Lin

Vertex’s Orkambi Racks Up Another Approval For Cystic Fibrosis
2022-09-05
BioCryst’s ALK-2 Inhibitor Granted FDA Orphan Drug Status For Rare Bone Disease
2022-09-01
Jounce’s Antibody Misses Primary Endpoint In Phase 2 Lung Cancer Study
2022-08-31
Takeda Walks Away From Microbiome Deal With Finch
2022-08-29
Japan Approves AstraZeneca’s Complement Inhibitor For Rare Muscle Disorder
2022-08-26
FDA Approves Abbott’s Burst Stimulation Therapy For Chronic Pain
2022-08-25
EMA Accepts Daiichi Sankyo’s Marketing Application For Leukemia Drug
2022-08-24
Alcon Acquires Aerie For $770 Million, Adding Eye Drops To Portfolio
2022-08-24
Ginkgo Bioworks Buys Baktus’ Epidemic-Predicting Tools
2022-08-22
Bluebird Bio’s Zynteglo Becomes First FDA-Approved Gene Therapy For Beta-Thalassemia
2022-08-18
Orna Therapeutics Secures Multi-Billion RNA Deal With Merck After $221 Million Series B
2022-08-17
Ipsen Completes $247 Million Oncology Buyout Of Epizyme
2022-08-15
FDA Finds Carcinogen In Merck’s Diabetes Drug, Allows Continued Sales To Avoid Shortage
2022-08-11
Merck Dangles $1.1 Billion For Cerevance To Discover New Targets For Alzheimer’s
2022-08-10
Bayer, Orion’s Prostate Cancer Drug Gets Approval For Second Indication
2022-08-10
1 8 9 10 11 12 25
Scroll to Top